Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Pharma And Biotech CRM Software Market In The Coming Years?

The market size for CRM software in pharma and biotech has been quickly expanding over the past few years. The market growth is projected to rise from $7.39 billion in 2024 to $8.7 billion in 2025, registering a compound annual growth rate (CAGR) of 17.6%. Factors contributing to this historic growth include the shift towards customer-centric strategies, broadened sales and marketing avenues, escalating demands for data analytics, heightened necessity for efficiency and productivity, and an emphasis on improving the customer experience.

The market size of pharma and biotech CRM software is projected to experience a quick expansion in the upcoming years, with a predicted growth to $16.06 billion by 2029, expanding at a CAGR of 16.6%. The substantial growth predicted during this period is primarily attributable to a focus on AI-driven customer understanding, increasing virtual interaction solutions, integration into the healthcare ecosystem, enhanced compliance and data security, and a broadened scope for mobile and remote access. The primary trends for the forecast period are expected to be AI-driven customer insights, predictive analytics for those providing healthcare, a patient-focused approach, virtual interaction solutions, and a strong focus on digital marketing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15442&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Pharma And Biotech CRM Software Market?

The surge in personalized medicine requirements is poised to spur the pharma and biotech CRM software market’s evolution. Personalized medicine refers to a medical strategy that tailors healthcare verdicts and therapies for patients based on their genetic constitution, environmental influences, and lifestyle. The mounting demand for such medicines is stimulated by a higher cancer prevalence and an escalating occurrence of chronic illnesses in the population. The need for individualized medicine obliges the application of pharma and biotech CRM software to efficiently handle patient data, track therapy outcomes, and support personalized healthcare provision. As an illustration, the Personalized Medicine Coalition, a professional society based in the US, reported that 12 fresh individualized medications got approved in 2022, making up approximately 34% of all new treatment approvals, a marked augmentation over previous years. Hence, the burgeoning demand for personalized medicine is fueling the pharma and biotech CRM software market’s expansion.

Which Sub-Segments Are Driving Growth Within The Pharma And Biotech CRM Software Market?

The pharma and biotech crm softwaremarket covered in this report is segmented –

1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)

2) By Deployment: On-Premises; Cloud Based

3) By Enterprise Size: Large Enterprise; Small And Medium Enterprise (SMEs)

4) By Industry: Pharmaceuticals; Biotech

Subsegments:

1) By Artificial Intelligence Customer Relationship Management (CRM): AI-Powered Sales Automation; AI-Driven Customer Insights And Analytics; Predictive Analytics For Lead Scoring; Chatbots And Virtual Assistants; Natural Language Processing (NLP) For Customer Interaction; Personalized Marketing And Campaign Management; Sentiment Analysis And Customer Feedback Analysis; Machine Learning For Sales Forecasting

2) By Conventional Customer Relationship Management (CRM): Contact And Lead Management; Sales Pipeline And Opportunity Management; Marketing Automation And Campaign Management; Customer Service And Support Modules; Email Marketing And Communication Tools; Customer Segmentation And Targeting; Activity Tracking And Reporting; Integration With ERP And Other Business Systems

What Future-Focused Trends Are Anticipated In The Pharma And Biotech CRM Software Market?

Prominent firms in the pharma and biotech CRM software market are progressively integrating artificial intelligence (AI) and machine learning features into platforms, such as AI-driven personalized engagement platform, to accommodate the escalating need for advanced client relationship management tools designed for the pharmaceutical and biotechnology sectors. The use of AI-powered personalized engagement helps these companies to convey appropriate and targeted messages to healthcare professionals, patients, and other relevant parties. For example, Salesforce, Inc., an American company that offers cloud-based software solutions, introduced its novel life sciences cloud in October 2023. This platform leverages data, automation, and trusted AI to facilitate patient interaction and clinical procedures for pharmaceutical and medical technology enterprises. It also offers streamlined management of patient engagement, clinical operations, commercial lifecycle, and customized experiences for stakeholders throughout the drug and device development process.

Which Players Are Shaping The Competitive Landscape Of The Pharma And Biotech CRM Software Market?

Major companies operating in the pharma and biotech CRM software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pharma-and-biotech-crm-software-global-market-report

How Do Regional Dynamics Influence The Pharma And Biotech CRM Software Market Performance?

North America was the largest region in the pharma and biotech CRM software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15442&type=smp

Browse Through More Reports Similar to the Global Pharma And Biotech CRM Software Market 2025, By The Business Research Company

Pharmaceutical Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Biopharmaceutical Cmo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

E Pharmacy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model